| pubmed-article:16186073 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16186073 | lifeskim:mentions | umls-concept:C0282402 | lld:lifeskim |
| pubmed-article:16186073 | lifeskim:mentions | umls-concept:C0043210 | lld:lifeskim |
| pubmed-article:16186073 | lifeskim:mentions | umls-concept:C0040053 | lld:lifeskim |
| pubmed-article:16186073 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:16186073 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:16186073 | lifeskim:mentions | umls-concept:C0333348 | lld:lifeskim |
| pubmed-article:16186073 | lifeskim:mentions | umls-concept:C0428528 | lld:lifeskim |
| pubmed-article:16186073 | lifeskim:mentions | umls-concept:C2745888 | lld:lifeskim |
| pubmed-article:16186073 | lifeskim:mentions | umls-concept:C0694643 | lld:lifeskim |
| pubmed-article:16186073 | lifeskim:mentions | umls-concept:C0332167 | lld:lifeskim |
| pubmed-article:16186073 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:16186073 | pubmed:dateCreated | 2005-9-27 | lld:pubmed |
| pubmed-article:16186073 | pubmed:abstractText | In the estrogen in venous thromboembolism (EVTET) study of 140 women with a history of venous thromboembolism (VTE), oral hormone replacement therapy (HRT) was associated with strong activation of coagulation markers and increased risk of recurrent VTE. No such associations were observed in the estrogen women atherosclerosis (EWA) study of 118 women with established coronary artery disease who were given transdermal HRT. | lld:pubmed |
| pubmed-article:16186073 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16186073 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16186073 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16186073 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16186073 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16186073 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16186073 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16186073 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16186073 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16186073 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16186073 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16186073 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16186073 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16186073 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16186073 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16186073 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16186073 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:16186073 | pubmed:issn | 0378-5122 | lld:pubmed |
| pubmed-article:16186073 | pubmed:author | pubmed-author:SandsetPer... | lld:pubmed |
| pubmed-article:16186073 | pubmed:author | pubmed-author:OsIngridI | lld:pubmed |
| pubmed-article:16186073 | pubmed:author | pubmed-author:HøibraatenEls... | lld:pubmed |
| pubmed-article:16186073 | pubmed:author | pubmed-author:SandvikLeivL | lld:pubmed |
| pubmed-article:16186073 | pubmed:author | pubmed-author:AndersenTrine... | lld:pubmed |
| pubmed-article:16186073 | pubmed:author | pubmed-author:EilertsenAnet... | lld:pubmed |
| pubmed-article:16186073 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16186073 | pubmed:day | 16 | lld:pubmed |
| pubmed-article:16186073 | pubmed:volume | 52 | lld:pubmed |
| pubmed-article:16186073 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16186073 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16186073 | pubmed:pagination | 111-8 | lld:pubmed |
| pubmed-article:16186073 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:16186073 | pubmed:meshHeading | pubmed-meshheading:16186073... | lld:pubmed |
| pubmed-article:16186073 | pubmed:meshHeading | pubmed-meshheading:16186073... | lld:pubmed |
| pubmed-article:16186073 | pubmed:meshHeading | pubmed-meshheading:16186073... | lld:pubmed |
| pubmed-article:16186073 | pubmed:meshHeading | pubmed-meshheading:16186073... | lld:pubmed |
| pubmed-article:16186073 | pubmed:meshHeading | pubmed-meshheading:16186073... | lld:pubmed |
| pubmed-article:16186073 | pubmed:meshHeading | pubmed-meshheading:16186073... | lld:pubmed |
| pubmed-article:16186073 | pubmed:meshHeading | pubmed-meshheading:16186073... | lld:pubmed |
| pubmed-article:16186073 | pubmed:meshHeading | pubmed-meshheading:16186073... | lld:pubmed |
| pubmed-article:16186073 | pubmed:meshHeading | pubmed-meshheading:16186073... | lld:pubmed |
| pubmed-article:16186073 | pubmed:meshHeading | pubmed-meshheading:16186073... | lld:pubmed |
| pubmed-article:16186073 | pubmed:meshHeading | pubmed-meshheading:16186073... | lld:pubmed |
| pubmed-article:16186073 | pubmed:meshHeading | pubmed-meshheading:16186073... | lld:pubmed |
| pubmed-article:16186073 | pubmed:meshHeading | pubmed-meshheading:16186073... | lld:pubmed |
| pubmed-article:16186073 | pubmed:meshHeading | pubmed-meshheading:16186073... | lld:pubmed |
| pubmed-article:16186073 | pubmed:meshHeading | pubmed-meshheading:16186073... | lld:pubmed |
| pubmed-article:16186073 | pubmed:meshHeading | pubmed-meshheading:16186073... | lld:pubmed |
| pubmed-article:16186073 | pubmed:meshHeading | pubmed-meshheading:16186073... | lld:pubmed |
| pubmed-article:16186073 | pubmed:meshHeading | pubmed-meshheading:16186073... | lld:pubmed |
| pubmed-article:16186073 | pubmed:meshHeading | pubmed-meshheading:16186073... | lld:pubmed |
| pubmed-article:16186073 | pubmed:meshHeading | pubmed-meshheading:16186073... | lld:pubmed |
| pubmed-article:16186073 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16186073 | pubmed:articleTitle | The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis. | lld:pubmed |
| pubmed-article:16186073 | pubmed:affiliation | Department of Hematology, Faculty Division, Ullevaal University Hospital, Oslo, Norway. a.l.eilertsen@medisin.uio.no | lld:pubmed |
| pubmed-article:16186073 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16186073 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:16186073 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:16186073 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16186073 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16186073 | lld:pubmed |
